Oxamniquine Derivatives Overcome Praziquantel Treatment Limitations for Schistosomiasis
S. N. Alwan, A. B. Taylor, J. Rhodes, M. Tidwell, S. F. McHardy, P. T. LoVerde
This paper identifies novel oxamniquine derivatives that overcome praziquantel limitations in treating schistosomiasis by killing all three Schistosoma species and resistant strains.
bioRxiv · May 23, 2023Biochemistry